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1.  INTRODUCTION 
 
Diabetes mellitus (DM) is a worldwide problem and the most 
common endocrine disorder. Its prevalence is increasing in the present 
scenario of a sedentary lifestyle in the general population. Abnormalities of 
insulin and elevated blood glucose level lead to metabolic, vascular, 
neurological and immunological abnormalities. Affected organs include 
the cardiovascular, renal and nervous systems, eyes and the skin. [1] The 
skin is affected by both the acute metabolic derangements and the chronic 
degenerative complications of diabetes. Although the mechanism for many 
diabetes associated skin conditions remains unknown, the pathogenesis of 
others is linked to abnormal carbohydrate metabolism, other altered 
metabolic pathways, atherosclerosis, microangiopathy, neuron 
degeneration and impaired host mechanisms. [2] The association of certain 
skin diseases with DM has been fairly well recognized with an incidence 
rate ranging from 11.4 [3] to 71%. [4] 
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2.  AIM OF THE STUDY 
 
Aims & objectives: 
 
1. To assess the prevalence of diabetes mellitus association with 
skin disorder in population in and around Tirunelveli in all 
population attending the out patient and inpatient in 
Tirunelveli medical college hospital 
 
2. To assess the correlation of skin diseases with systemic 
manifestation of diabetes mellitus. 
 
3. To assess the pattern of skin lesions which are commonly 
associated with diabetes. 
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3. REVIEW OF LITRATURE 
DIABETES   
Definition 
Diabetes mellitus is a group of metabolic diseases characterized by 
hyperglycemia resulting from defects in insulin secretion, insulin action or 
both. 
Criteria for diagnosis 
Fasting          > 126mg% 
Postprandial  > 200mg% 
Symptoms of diabetes plus Random Blood Glucose>200mg% 
Classification[5] 
Type 1 Diabetes mellitus 
Type 2 Diabetes mellitus 
Other Specific Types 
Gestational Diabetes 
Type 1 Diabetes Mellitus  
Definition 
Diabetes mellitus (DM) comprises a group of common metabolic 
disorders that share the phenotype of hyperglycemia. 
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Caused by a complex interaction of genetics, environmental factors, 
and lifestyle choices 
Classified on the basis of a pathogenic process leading to 
hyperglycemia 
Results from pancreatic beta-cell destruction, usually leading to 
absolute insulin deficiency 
Type 1A DM results from autoimmune beta-cell destruction, which 
leads to insulin deficiency. 
Type 1B DM lacks immunologic markers indicative of an 
autoimmune destructive process of beta cells, but like type IA DM, it is a 
ketosis-prone insulin deficiency that develops by unknown mechanisms. 
Epidemiology 
Worldwide prevalence: dramatic increase over past 2 decades and 
projected to increase further 
Incidence 
Incidence varies by geography. 
Believed to reflect the frequency of high-risk human leukocyte 
antigen (HLA) alleles among ethnic groups in different geographic 
locations 
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Scandinavia: highest incidence (e.g., Finland, 35 cases per 100,000 
persons yearly) 
Northern Europe and U.S.: intermediate rate (8–17 cases per 100,000 
persons yearly) 
Pacific Rim: much lower rate (Japan and China, 1–3 cases per 100,000 
persons yearly) 
Age of onset 
Can develop at any age, but often in childhood or early teens 
Usually <30 years of age 
Of persons who develop DM after 30 years of age, ~5–10% have type 
1A DM. 
 
Type 2 DM  
A heterogeneous group of disorders characterized by variable 
degrees of insulin resistance, impaired insulin secretion, and increased 
glucose production  
  Preceded by a period of abnormal glucose homeostasis, classified as 
impaired fasting glucose (IFG) or impaired glucose tolerance (IGT)  
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Common characteristics 
Development of DM after 30 years of age 
Obese (80%) 
Elderly persons may be lean. 
May not require insulin initially 
May have associated conditions (e.g., hypertension, cardiovascular 
disease, dyslipidemia, or polycystic ovary syndrome) 
Insulin resistance often associated with central obesity and 
hypertriglyceridemia 
 
Epidemiology 
DM Worldwide prevalence: greatly increased over past 2 decades 
Prevalence 
 By age (in 2000) 
<20 years: 190 cases per 100,000 persons 
≥20 years: 8,600 cases per 100,000 persons 
>65 years: 20,100 cases per 100,000 persons 
By sex 
Most age ranges: equal in men and women 
>60 years of age: slightly more men than women 
By race (in the U.S. in 2000) 
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African Americans: 13,000 cases per 100,000 persons 
Hispanic Americans: 10,200 cases per 100,000 persons 
Native Americans (American Indians and Alaska natives): 15,500 
cases per 100,000 persons 
Non-Hispanic white persons: 7,800 cases per 100,000 persons Type 2 
DM 
             Incidence/prevalence varies by geography (likely owing to genetic, 
behavioral, and environmental factors). 
Highest: certain Pacific islands 
Intermediate: India and U.S. 
Relatively low: Russia and China 
Prevalence is expected to increase more rapidly than type 1 DM 
because of increasing obesity and reduced activity levels 
Age of onset 
     Can develop at any age 
     Typically develops with increasing age, >30 years of age 
     Age of diagnosis is decreasing in some ethnic groups. 
     Occurs at an earlier average age in ethnic groups other than non 
Hispanic whites 
      Marked increase among overweight children and adolescents.                      
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Other specific types of diabetes 
Maturity-onset diabetes of the young (MODY) and genetic defects of 
beta-cell   
Function. Characterized by mutations in: 
Hepatocyte nuclear transcription factor (HNF) 4α (MODY 1) 
Glucokinase (MODY 2) 
HNF-1α (MODY 3) 
Insulin promoter factor 1 (MODY 4) 
HNF-1β (MODY 5) 
NeuroD1 (MODY 6) 
Mitochondrial DNA 
Proinsulin or insulin conversion 
Diagnostic Approach 
National Diabetes Data Group and World Health Organization 
criteria for DM 
Based on the following premises: 
Fasting plasma glucose (FPG) and response to oral glucose load vary 
among normal  persons. 
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   DM is defined as the level of glycemia at which diabetes-specific 
complications occur  rather than as deviations from the population-based 
mean. 
Hemoglobin A1C  
• Standard method for assessing long-term glycemic control 
6%: 7.5 mmol/L (135 mg/dL) 
7%: 9.5 mmol/L (170 mg/dL) 
8%: 11.5 mmol/L (205 mg/dL) 
  A 1% increase in the hemoglobin A1C level translates into a 2.0-
mmol/L (35-mg/dL) increase in the mean glucose level. 
Screening laboratory tests for DM-associated conditions 
• Microalbuminuria 
       Spot urine microalbumin/creatinine ratio (beginning 5 years after 
onset of type 1 DM) 
       Microalbuminuria is defined by a microalbumin/creatinine ratio >30 
mg/g creatinine. 
• Dyslipidemia 
       Fasting lipid profile (annual) 
• Thyroid dysfunction 
        Serum thyroid-stimulating hormone 
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Factors to consider in developing goals of therapy 
Age 
Ability to understand and implement complex treatment regimen 
Presence and severity of complications 
Ability to recognize hypoglycemic symptoms 
Presence of other medical conditions or treatments that might alter 
response to therapy 
Lifestyle and occupation (e.g., possible consequences of experiencing 
hypoglycemia on the job) 
Level of support available from family and friends 
Life expectancy at time of diagnosis 
Presence of microvascular complications 
     Hemoglobin A1C level: <7.0% 
Provide patient with educational and pharmacologic resources 
necessary to reach goal. 
Monitor/treat DM-related complications. 
  
Comprehensive care 
Best accomplished by a multidisciplinary team approach o Primary 
care provider and/or endocrinologist or diabetologist o Certified diabetes 
educator o Nutritionist 
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Subspecialists with experience in treating DM-related complications 
¾ Neurologist 
¾ Nephrologist 
¾ Vascular surgeon 
¾ Cardiologist 
¾ Ophthalmologist 
¾ Podiatrist 
¾ Dermatologist  
Goals of diabetes management during hospitalization 
Avoid hypoglycemia. 
Optimize glycemic control. 
Maintain near-normal glucose levels with insulin. 
Transition the patient back to outpatient diabetes treatment regimen. 
Optimal glycemic control in hospitalized patient 
Preprandial glucose level: <6.1 mmol/L (100 mg/dL) 
Postprandial glucose level: <10 mmol/L (180 mg/dL) 
Complications  -  Acute complications 
Diabetic ketoacidosis. 
Hyperglycemic hyperosmolar state 
          Primarily seen in patients with type 2 DM 
Hyperosmolar Hyperglycemic State  
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Chronic complications 
    Responsible for majority of morbidity and mortality associated with 
DM 
   Leading cause of adult blindness, nontraumatic lower-extremity 
amputation, and end-  stage renal disease in the U.S. 
   Risk increases with duration of hyperglycemia. 
    Usually becomes apparent in second decade of hyperglycemia 
Microvascular 
1. Eye disease 
Retinopathy (nonproliferative or proliferative) 
Macular edema 
Other nonvascular eye disease (cataracts, glaucoma) 
2. Neuropathy 
  Sensory and motor (mononeuropathy and polyneuropathy) 
  Autonomic 
3. Nephropathy 
Macrovascular 
Cardiovascular Complications of Diabetes Mellitus for details. 
Coronary artery disease 
Peripheral vascular disease 
Cerebrovascular disease 
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G I T  
   Gastroparesis 
   Diarrhea 
  Genitourinary 
 Lower extremity 
 Amputation 
        DM is the leading cause of nontraumatic lower-extremity 
amputation in the U.S. 
   Foot ulcers and infections 
The interaction of several pathogenic factors promote development. 
Neuropathy 
Disordered proprioception 
Abnormal foot biomechanics 
Peripheral arterial disease 
Poor wound healing 
Approximately 15% of patients with DM develop a foot ulcer. 
A significant subset undergo amputation; risk is 14–24% with that 
ulcer or subsequent ulcers. 
Risk factors for foot ulcers or amputations 
      Male sex 
       DM >10 years 
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      Peripheral neuropathy 
      Abnormal structure of foot (bony abnormalities, callus, thickened 
nails) 
      Peripheral arterial disease  
      Smoking 
     History of previous ulcer or amputation 
      Poor glycemic control 
Infectious 
Persons with diabetes have a greater frequency and severity of 
infection. 
Osteomyelitis 
Pneumonia 
Urinary tract infections 
Skin and soft-tissue infections 
Several rare infections occur almost exclusively in DM.  
Rhinocerebral mucormycosis Emphysematous infections of gall 
bladder and urinary tract 
“Malignant” or invasive otitis externa  
Fournier’s syndrome, a necrotizing fasciitis most commonly 
confined to the groin 
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Dermatologic 
Common features 
Protracted wound healing 
Skin ulcerations 
Xerosis and pruritus 
Diabetic dermopathy (pigmented pretibial papules or “diabetic skin 
spots”) 
Bullous diseases (shallow pretibial ulcerations or erosions) 
Necrobiosis lipoidica diabeticorum 
Rare disorder that predominantly affects young women with type 1 
DM, neuropathy, and retinopathy.Begins in the pretibial region as an 
erythematous plaque or papules that gradually enlarge, darken, and 
develop irregular margins, with atrophic centers and central 
ulceration.May be painful 
Granuloma annulare 
Scleredema 
Lipoatrophy and lipohypertrophy  Can occur at insulin injection 
sites o Unusual with human insulin 
Metabolic syndrome  
 (also referred to as Syndrome X or Insulin Resistance Syndrome)  
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Describes a cluster of CVD risk factors and metabolic alterations 
associated with excess  body fat. 
WHO Definition 
   IGT / IFG/T2DM  + any of the two below 
           Increased Waist-Hip Ratio (M:>0.9, F: >0.85) 
           Elevated Blood Pressure>140/90 mm Hg 
           Elevated Triglycerides>150mg/dl 
           Low HDL cholesterol 
           Microalbuminuria 
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DERMATOLOGIC LESIONS IN DIABETES 
Numerous skin lesions are associated with either type 1 or type 2  
diabetes mellitus, specific chronic complications of the disease, use of 
antibiotic drugs, and certain endocrine  and metabolic disorders that cause 
secondary diabetes mellitus. Varies cutaneous manifestations are 
significantly associated with diabetes compared to control groups[6]   
 
Classification of  Dermatologic lesions of diabetes mellitus[7]  
There is no strict classification of skin lesions related to diabetes 
mellitus, therefore grouping them under the following headings will give 
us an idea about various types of skin lesions occurring in diabetes. 
 
Dermatologic lesion associated with but not specific for diabetes 
mellitus  (SKIN MARKERS) 
¾ Prurites 
¾ Necrobisis lipoidica diabeticorum 
¾ Granuloma annulare 
¾ Diabetic dermopathy 
¾ Scleroderma like syndrome 
¾ Acanthosis nigricans  
¾ Diabetic bulla 
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Skin alterations due to diabetic complications  
¾ Diabetic foot 
¾ Cutaneous infections associated with diabetes  
 Furunculosis 
 Carbuncle 
 Pyoderma 
 Candiasis 
 Dermatophytosis 
 Erythrasma 
 Xanthomatosis 
 Pycomycosis 
 Malignant otitis media 
 
1. Dermatological changes associated with neurovascular 
complications 
¾ Macroangiopthy 
¾ Microangiopathy 
¾ Diabetic neuropthy 
2. Dermatologic complications of diabetes treatment 
¾ With oral hypoglycemic agent 
¾ With insulin  
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3. Endocrine syndromes with skin alterations and diabetes mellitus 
¾ Migratory necrolytic erythema in glucogonama 
 
4. Dermatoses that are more common in diabetes mellitus 
¾ Perforating dermatosis 
¾ Vitiligo 
¾ Lichen planus  
¾ Eruptive xanthoma 
¾ Kaposi sarcoma 
¾ Bullous pempigoids 
¾ Dermatitis herpatiformis 
¾ Psoriasis 
 
Various types of dermatological lesions in details 
1. Dermatologic lesion associated with but not specific for diabetes 
mellitus  
PRURITIS 
Genralized pruritis was once considered a typical symptoms of 
diabetes but its frequency is unknown. Studies have failed to provide a 
statistical basis for this belief. [8] .  A higher rate of pruritis is found in liver 
disease, uremia, parasitic infestations, endocrine disorders(thyroid), 
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malignant disease, hematological and metabolic diseases and as a side 
effects of some drugs.  
Genralized pruritsis associated with diabetes complications of 
chronic renal insufficiency, occationally neuropathy(irritation of nerve 
ending can cause). High level of urea in the  blood  cause the skin to itch. 
Candidiasis  or dermatophytosis may underlie pruritis  in diabetic patient. 
Anorectal pruritis is often caused by candidiasis in diabetic .  
Ringworm is appear on the feet. groin, trunk, scalp,or nails. Itching 
in the elderly diabetes is not a feature of hyperglycemia but rather a 
manifestation of xerosis. Simple lupricants and low potency corticosteroids 
application should prove helpful.  
      
NECROBISIS LIPOIDICA DIABETICORUM 
Occurring in 7 % of the diabetic patients[9]. These relatively  
asymptomatic  more common in women. It is one of the cutaneous markers  
of  diabetic. In insulin users the onset is considered to occur earlier than 
type 2 diabetes  or non diabetes.  The lesions are characteristically found on 
the anterior and lateral surfaces of lower legs i.e  in the pretibial and 
medial malleolar region. They may also present on the face ,arms and 
trunks. There may be one or several lesions, either unilateral or bilateral. 
The lesions begins as a small dusky-red elevated nodule with a sharply 
circumscribed border.  It slowly enlarged to turn into a plague of irregular 
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outline, flattened, and eventually depressed as the dermis become more 
atrophic.  
The color turns more brownish-yellow except for the border, which 
may remain red. The epidermis is smooth or slightly scaly and atrophic. 
Delicate vessels can be seen through the surface. The lesions may be 
anesthetic or reduced sensation to pin prick and to fine touch due to 
destruction of cutaneous nerve. 
The chronic lesion of NLD are indolent; shallow, often painful ulcer 
frequently appear as long standing lesion.  In the early stages, NLD may 
resemble granuloma annulare or sarcoid, but a well developed plaque is 
characteristic and easily recognized.  The primary pathologic changes are 
in the lower dermis, where collagen is markedly altered with focal area of 
loss of normal structure., swelling basophilia and distortion of bundles 
(necrobiasis). There is increased collaginase and aggregation of 
inflammatory cells in the lesion which later gives the appearance of foam 
cells account for the designation of ‘lipoidica’.  The nature of association 
with diabetes and its pathogenesis remains unclear.  Because NLD occurs 
both IDDM and NIDDM, its pathogenesis cannot be related to genetic 
factors, underlying autoimmune disease or other cause of diabetes. The 
treatment of NLD is not very satisfactory progression of lesion does not 
correlate with normalization of the hyperglycemia.  Topical application of 
glucocorticoids under occlusion or by intralesional injection may afford 
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some improvement of active lesion.  Ultraviolet treatment has been found 
to be control when it is flaring. 
 
GRANULOMA ANNULARE 
It is a benign necrobiotic condition associated with lesion similar to 
NLD, the only difference being the absence of atrophy.  This is a skin 
disease usually seen in children and young adults. It is occasionally seen 
with diabetes. It is characterized by red spots in the initial stages that 
expand outwards in a ring like fashion. The hands especially the fingers, 
on dorsal or lateral aspect of the hands and elbows (forearm) are 
commonly affected. Patient  with widespread graluma annulare need to be 
screened for diabetes mellitus.  Mostly it is asymptomatic and resolve 
spontaneously. 
DIABETIC DERMMOPATHY 
It is  common skin lesion occurring in diabetes . It is prominenent in 
males whom are more than 50 years of age[10] .  It is seen even in 
euglucemic, endocrine disease and in healthy individuals. The presence of 
small vessela changes had led to term diabetic dermopathy.  The lesions 
are asymptomatic, irregularly shaped patches occurring primarily over the 
anterior legs; their surface are depressed  and they have a light brown 
color.  The pigmentation is due to deposition of hemosiderin in histiocytes 
and extravascular superficial erythrocytes.   These lesion can occur in 
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upper arms,thigh, and any bony prominence. Lesions appears crops and 
gradually resolve over 12 to 18 months. The disorder is asymptomatic 
requiring no treatment except for protecting the area from any trauma and 
secondary infection. Use of  bioocclusive dressing is recommended. 
                     
SCLERODERMA-LIKE SYNDROME 
Scleroderma-like syndrome, reduced joint mobility, waxy skin 
syndrome  are synonymous  denoting one and the same skin disorders. 
Reduced joint mobility probably is the earliest complication of diabetes 
and a  characteristic finding in children and adolescents after only 10 years 
of diabetes duration.  The metacorpophalangeal joint  and proximal 
interphalengeal joint are usually first involved. Reduced extention ,initially 
active ,then also passive, is is observed. Flexion may for long remain 
completely preserved.  Clinicl signs include impossible extension of the 
palm on the table and impossible clasping hands as in prayer.  Restriction 
of passive extension of the interphalangeal and metacarpo-phalangeal is 
the most important from the diagnostic point of view. The skin become 
thickened, with waxy appearance,in about one third of patients[11] .Such 
skin lesions resemble sclerodermic skin.  Historically, dermal collagen 
thickening and elastic fibres reduction are observed.   
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ACANTHOSIS NIGRICANS 
Acanthosis nigricans  appears as velvety  hyperpigmented  
pappilomatous hyperplasia of epidermis primarily in flexural areas like 
axillary, inquinal, and inflammatory folds, and in creases of the neck. 
Acanthosis nigricans  is associated with two forms. The severe form is 
usually found with advanced malignancy particularly gastro intestinal 
tract. The more limited form is more frequently found in association with a 
variety of  endocrinopathies, including  acromegaly, cushing 
syndrome,and polycystic ovary disease.  A variety of endocrine diseases 
and acanthosis nigricans suggest that insulin resistance is a common 
denominator even in the absence of overt diabetes.  
Acanthosis nigricans has been associated with all three form of 
insulin resistance  
Type A in which insulin resistance is due to receptor defects 
resulting in decreased insulin binding.  
Type B in which insulin resistance is conferred by effects of 
circulating antireceptor antibodies.  
Type C in which post receptor defect including abnormalities in 
signal transduction such as autophosphorylation of the receptor  and 
activation of tyrosine kinase inhibit insulin action[12]. The use of keratolytic 
agents such as salicylic acid can improve the appearance cosmetically,  
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DIABETIC BULLAE 
The bullae appears spontaneously, commonly in the dorsum  and 
sides of the lower legs sometimes on forearm and hands. It may range 
from millemeters  to centimeters. The lesions are often bilateral and 
containing clear fluids. There is no surrounding erethema. Generally the 
bullae heel in several weeks without significant scarring and they may 
recur[13]. The bullae are subepidermal and ultrastructural studies have 
demonstrated  the plane of separation to in the basement membrane zone 
above the basal lamina. Neither trauma or immune mechanism have been 
implicated.  Usually do not need any treatment apart from prevention of 
secondary infection.   
   
2. Skin alterations due to Diabetic complications 
 Neurovascular and ischaemic changes and foot ulceration(diabetic foot) 
 Diabetic foot is a serious complication which results from confluence 
of multifactorial pathogenic mechanisms. Neuropathy (motor, sensory & 
autonomic) and diabetic angiopathy are the contributing factors for its 
development, the neuropathy being the major factor. Laceration which 
may be complicated with necrosis, gangrene and osteomyelitis, 
accentuated plantar arches and hammer toes with inter digital maceration 
leading to bacterial and fungal infections and loss of ankle jerk and 
vibration sensation are the features of diabetic foot. Because of its serious 
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nature it requires special attention. Prevention is by far more relavant than 
cure. Hence care of the foot must become a routine in diabetic patients. 
 
Cutaneous infections associated with diabetes 
 Poorly controlled or undiagnosed diabetics have a greater 
susceptibility to bacterial and fungal infections of skin. The most 
frequently encountered infections are staphylococcal pyodermas such as 
furunculosis and carbuncles, candidiasis erythrasma and dermatophytosis. 
Furunculosis (boils) 
The word boil refers to swelling. There is extended involvement of 
the hair follicle including the perifollicular region in the dermis and 
subcutaneous tissue, i.e, there is folliculitis as well as perifolliculitis. It is 
caused by staphylococcus aureus. Boils are common during adolescence 
and early adult season. Isolated furuncles appear and many lesions may 
develop together. Factors like diabetes mellitus, exfolliative dermatitis and 
intake of systemic steroids may be responsible for their increased 
frequency and greater severity. Those furuncles which do not discharge on 
the surface are called blind boils. 
  
Carbuncle 
  A group of boils which show deep infections of contiguous follicles 
with S.aureus. The infection spreads from one follicle to the other usually 
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not via the surface but through the sub cutaneous tissue. The lesion starts 
as a painful, tender, firm to hard indurated lump with a course similar to 
but more protracted than that of a furuncle. It is associated with intense 
inflammatory changes in the surrounding and underlying tissues. Pus is 
discharged not necessarily due through the follicular openings but from 
any point. The common sites are back of the neck, shoulders, hips and 
thighs. It is frequently associated with diabetes mellitus. If the underlying 
conditions are controlled and appropriate therapy instituted, healing takes 
place leaving a scar; otherwise toxaemia and even death may follows. 
 
Pyodermas 
The advent of antibiotics and tighter control of diabetes has 
markedly reduced the incidence and morbidity of pyodermas which were 
formerly considered as serious complications. Lower extremities constitute 
a particular hazard of diabetic patient. The associated atherosclerosis and 
peripheral neuropathy lead to ulceration and gangrene as well as poor 
wound healing.   
Candidiasis (moniliasis) 
      Candida albicans is a common complication in poorly controlled 
diabetics[14] . They show considerable improvement when diabetes is 
controlled. Candidal infections of the skin may resemble those caused by 
other dermatophytes but are most common where skin is moist and in 
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contact with itself, e.g., groin, perineum, breast, axillae and vulvovaginal 
areas. Nail infections start at the base, forming ridges, often accompanied 
by paronychia. It is the infection of the web space brtween 3rd and 4th 
finger. In the mouth white curd like patches are seen, which can be scraped 
away leaving a bleeding base. Atrophy of the gums and angular stomatitis 
are common in elderly.                                         
                                         Balanitis and Balanoposthitis 
   Balanitis is common among elderly and uncircumscribed patients. 
Balanoposthitis usually presents with itching, pain, erotions, cracks and 
whitish scales on the terminal portions of the prepuce. Diabetes is often the 
underlying disease. In diabetics or immunosuppressed, a severe 
edematous, ulcerative balanitis may occur. Phimosis has been observed as 
a common complaint in diabetic men and recurring candidal infection is 
usual cause.  
Dermatophytosis 
  It is encouraged by sharing of wash places and ringworm is due to 
dermatophyte fungi infection. There are three main genera: Trichophyton; 
Microsporum; and Epidermophyton. Clinical features depends on the site 
and species. 
Tinea pedis 
  Most common type of fungal infection. The sharing of wash places 
and swimming pools encourages it. Infrequent washing of socks and use of 
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occlusive footwear encourages relapses. It may present as Interdigital 
scaling, diffuse powdery scaling of soles and recurrent bouts of 
vesiculation of soles. The organisms involved are T.rubrum, 
T.mentagrophytes var.interdigitale, and E.floccosum. 
 
Tinea unguium:  
Toe nail infection is more common than finger nail infection and is 
often accompanied by tinea pedis. Usually only few nails or involved. 
Changes first occur at the free edge of the nail, which becomes yellow and 
crumbly. Thickening of nail and separation of the nail from the nail bed 
follows. T.rubrum is usual cause.                                                         
Tinea manuum 
It is usually asymmetric and involves palms (dry powdery scaling 
picking out of creases) more often than back of hands. 
Tinea cruris 
  It infects men more often than women and causes well demarcated 
redness and peripheral scaling of groins and upper thighs. A few vesicles 
or pustules are usually seen with the lesions. Eruption is often unilateral or 
asymmetric and itchy.  
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Tinea corporis: 
It is archetypal ringworm eruption. Erythematous scaly plaques 
expand slowly and clear in the center, leaving a ring-like pattern are 
characteristic.  
Erythrasma 
 The lesions are reddish, in fact, reddish brown in early stage which 
is not generally observed at this stage. After a period of time, the lesions 
become brownish-black with irregular but very well defined margins. They 
are smooth but later appear creased and even finely scaly. The sites of 
predilection are genito crural folds, axillae and submammary folds. The 
coryneforms causing erythrasma are seen in large sections of population in 
the interdigital web spaces where they produce only mild scaling. The 
lesions fluoresce coral red under wood’s light or UVA light, due to 
coproporphyrin III production by bacteria. If the patient has recently taken 
bath, the fluorescence may not be observed, as the porphyrin is soluble in 
water.     
Xanthomatosis 
Eruptive xanthomas are characteristic but uncommon complication 
of diabetics associated with more sustained hyperlipidaemia affecting 
plasma triglycerides and cholesterol more than phospholipids and 
hyperglycemia with glycosuria.  The decreased lipoprotein lipase activity 
in insulin dependent diabetics results in the accumulation of serum 
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triglycerides, whose levels are occasionally highly elevated to produce 
eruptive xanthomas. 
Cutaneous xanthomas results from deposition of lipid in the 
histocytes in the dermis or sub cutaneous tissue. It may be pruritic initially. 
Rapid regression of these lesions occurs hyperlipidaemia is brought under 
control. 
Xanthelasma 
It occurs  hyperlipidaemic states including diabetes. It does not 
regress with therapy for diabetes. A yellowish discoloration of the skin of 
the palms, soles and nasolabial folds due to deposition of carotene present 
in excess quantities in plasma may be associated with hyperlipidaemia 
even in the absence of xanthomatosis in diabetes. 
                                                     Phycomycetes infection 
 Hyperglycemia may permit organisms that are pathogenic to 
produce infection in traumatized skin, which may lead to gangrene and 
loss of the limb. There are various factors , which help the phycomycetes  
establish and  lead to the infection. These factors include pre-exsisting leg 
ulcers, nonhealing surgical wounds, deep seated fungal infections, etc., 
treatment must be aggressive, consisting of correcting acid-base balance, 
debridement of devitalized tissue and intravenous antifungal therapy. 
Patients with uncontrolled diabetes mellitus and ketosis may be 
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predisposed to deep fungal infections or rhinocerebral mucormycosis of 
the turbinates, septum, palate, maxillary and ethmoid sinuses[15] . 
                                                 Malignant otitis media 
 It is caused Pseudomonas aeroginosa. It is an uncommon but a very 
serious infection. Initially there is purulent discharge and in the external 
ear canal. It occurs commonly in diabetic men. It begins as a cellulitis and 
progress to chondritis , osteomyelitis, and infective cerebritis. It usually has 
fatal outcome.  
3. Dermatologic changes associated with neurovascular complications of 
diabetes 
                                                Macroangiopathy 
 Patients with diabetes mellitus have a slightly higher incidence and 
prevalence of large vessel disease compared with control subjects. In 
patients with IDDM or NIDDM, both low-density lipoprotein cholesterol 
and VLDL triglycerides are risk factors. Atherosclerosis of the arteries of 
the legs results in skin atrophy, hair loss, coldness of toes, nail dystrophy, 
pallor on elevation and mottling on dependence. A reliable sign of large 
vessel disease is dependent rubor with delayed return of color after 
pressure has been applied to skin[16] . 
                                                     Microangiopathy 
The role of diabetic microangiopathy is not completely understood. 
The signs include diabetic dermopathy, pigmented purpura, erysipelas 
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such as erythema, NLD,periungual telangiectases and diabetic  foot[17] . 
Other signs of microangiopathy include cutaneous reactive hyperemia and 
reduced capillary flow on cold or warm challenges of the patients with 
IDDM and those with MIDDM, as measured by Laser Doppler flowmerty. 
The thickening of the vessel walls, perivascular deposition of 
material reactive with periodic acid-schiff stain, and clumping of the elastic 
fibers in the papillary dermis are produced by a combination of intimal 
hyperplasia and increased deposition of type IV collagen within and 
around the vessel wall. The space between the pericytes and the 
endothelial cells is wider and the cytoplasmic processes that formed the 
contact point between them is longer and thinner than normal, suggesting 
a possible explanation for increased permeability[18] . The capillary leakage 
leads to the loss of albumin and water and the platelets have a higher 
tendency to aggregate. As a result, increased whole blood and plasma 
viscosity creates a sluggish microcirculation. 
   Diabetic rubiosis is a peculiar rosy reddening of the face, sometimes 
of the hands and feet, which may be observed in longstanding diabetics. It 
has been attributed to diabetic microangiopathy or decreased vascular 
tone. 
Diabetic neuropathy 
Elderly patients in whom the onset of diabetes is insidious are 
especially at risk of developing diabetic neuropathy. A common 
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neuropathy in diabetes mellitus is a distal, symmetric, mixed 
polyneuropathy involving both motor and the sensory nerves[19]. 
The skin manifestations of autonomic neuropathy in diabetes 
mellitus are disturbances in sweating and peripheral hyperaemia with 
eryrhema, edema, and atrophy. Motor neuropathy of the feet leads to 
imbalance between flexor and extensor muscles, displacement of fat pads 
and subluxation of digits.  
Typical signs of sensory neuropathy in diabetes mellitus are 
paraesthesia with loss of temperature and pain sensation, as well as aching 
and burning of the legs that worse at night. The combination of motor and 
sensory neuropathy along with mechanical factors and micriangiopathy 
plays a major role in development of diabetic foot. 
Immunohistochemical studies of nerves in diabetic skin have 
demonstrated depletion of neuropathies. The antidepressants such as 
desipramine and amitryptylline that inhibit the membrane pump 
mechanism for the reuptake of neuropeptides have proved effective in 
diabetic peripheral neuropathy. 
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4. Dermatologic complication due to treatment of diabetes 
Oral Hypoglycemic Drugs 
        The cutaneous complications of oral hypoglycemic agents are few. 
The first generation sulphonylureas such as chlorpropomide and 
tolbutamide, and usually develop in the first two months of treatment. 
Allergic skin reactions are uncommon. They are usually mild and self 
limited. Patients may present with intermittent or persistent pruritus or a 
maculo popular rash. Other cutaneous reactions which occur occasionally 
include urticaria and erythema multiforme, which may progress to steven-
johnson syndrome. Other rare skin manifestations include erythema 
nodosum and purpura as well as exacerbation of porphyria cutanea tarda 
and generalized hypersensitivity reactions. 
 The chlorpropomide alcohol flush occurs in the patients taking this 
drug. The reactions usually occur within 15 mins after ingestion of alcohol. 
It causes flushing, headache, tachycardia and dyspnoea that gradually 
subsides after an hour.                                                       
Insulin 
Cutaneous complications due to insulin therapy used to be common 
before advent of newer insulins. Allergic reactions to insulin may be 
immediate or delayed. Serious generalized reactions such as urticaria and 
anaphylaxis are rare.the immediate local reaction becomes is probably IgE 
mediated. It starts as erythema, becomes urticarial in 30 mins and subsides 
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in an hour. The delayed reaction is more common. It is due to delayed 
hypersensitivity. About 2 weeks after the initiation of insulin therapy, a 
pruritic nodule develops within 1to2 days at the site of injection, lasts for 
days and heal with hyper pigmentation and scarring. Localized induration, 
ulceration and scar formation and development of ketosis may result from 
faulty injection techniques. Idiosyncratic reactions are very rare and 
include pigmentation and occasionally keloid formation. Skin reactions 
resembling acanthosis nigricans has been reported. 
Insulin lipoatrophy and lipohypertrophy  which are the 
complications of the insulin injections, are rare after the introduction of 
newer insulins. Lipoatrophy presens as circumscribed atrophic plagues 
showing atrophy of the subcutaneous fat at the site of the insulin injection, 
and rarely shows complete resolution. It may be due to a local immune 
response to insulin injection[20] . 
Lipohypertrophy is  a soft dermal nodule . The overlying skin 
appears normal at the site of injection. It may be due to the lipogenic action 
of the insulin.  
Insulin edema occur on the abdomen and legs area are most 
common and usually a self-limiting complication which appear shortly 
after starting or increasing the dose of insulin. It is commonly seen in 
women and is unrelated to the cardiac or renal disease. The pathogenesis is 
unclear.  Ephedrine is the drug of choice[21]. 
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 5. Endocrine syndromes with the skin alterations and diabetes mellitus 
Glucagonoma 
It is the most characteristic endocrine syndrome manifesting with 
skin alteration and the diabetes mellitus and is often diagnosed later. The 
dermatosis is the clical clue. It is due to tumors of alpha cells glucogon 
secreting portion of the pancreas. It has four componenets 
 Hypersecretion of glucagons 
 Diabetes that is usually mild 
 Weight loss 
 Necrolytic migratory erethema. 
        Histologically they resemble pustular psoarisis, with the feature of 
intracellular edema in the upper extremities.,acanthosis and subcorneal 
pustulosis.  Necrolytic migratory erethema resolves after extirpation of the 
tumor, which in the majority of the cases is the treatment of choice[22].  
 
      6. Dermatosis reported to be more common in diabetics than in non 
diabetics. 
Kaposi sarcoma 
It is a multiple idiopathic hemorrhagic sarcoma, which manifest 
primarily as multiple nascular nodules in the skin and other organs. It 
predominently affects males. The lesions begins in the legs as multiple 
purple macules, nodules or plagues. Later the other area of the skin, 
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mucous membranes and the internal organ may be involved. Histological 
pictures reveal accumulation of the spindle cells forming vascular slits 
containing erethrocytes[23] . Diabetes mellitus has been reported with 
greater than expected frequency in the classic Kaposi sarcoma.  
Perforating  dermatosis 
There are several acquired cutaneous disorders having a common 
histological denominator the transepidermal elimination of the 
degenerative materials, chiefly collagen and elastic fibres. Many are seen in 
patient with chronic renal failure, particularly those on dialysis and with 
IDDM, or NIDDM. The size of the papules ranges from 2  to 10 mm in 
diameter, often with a keratotic plugs. The most patients are middle aged 
often block, and more often in men than women. Improvement of the itchy 
lesions is not achieved easily but retinoic acid[24] . and ultraviolet therapy 
has been useful.  
Vitiligo 
It is disease with a diminished or absent function of the melanocytes 
resulting in macular depigmentation and is found in mostly in perioral 
regions  and also on the extensor aspect of the extremities. It is 
asymptomatic. Vitiligo  occurs with a greater incidence than expected in 
patient with maturity onset diabetes. It is also reported in association with 
IDDM and other autoimmune disorders of the adrenal and thyroid gastric 
parietal cells.   
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Lichen planus 
An increased incidence of the diabetes mellitus and abnormal insulin 
response to glucose challenge have been claimed in patients with lichen 
planus. [25] . There are two types of lichen planus one is immunogenic type 
and another is  a metabolic defect type, both being associated with diabetes 
mellitus. 
Yellow nails 
The lesions  commonly involve distal hallux and is quite common in 
diabetics[26] .The earliest sign is yellow or brown color of the distal part of 
the hallux nail plate. Later  a cannry-yellowish discoloration occurs on the 
nails. It can involve finger nails and other toe nails during the later stage of 
the disease.  
Eruptive xanthomas 
It is frequently occur in uncotroller diabetes. The eruptions are 
multiple, firm, yellowish in color, waxy papules ranging from 1 to 4 mm in 
diameter, appearing in crops. They are mostly located on the extensor 
surfaces. The firm nontender papules are present on the 
knees,elbow,back.buttocks and trunk.the lesions are itchy, sometimes 
tender, surrounded by erethematous halo.they shows koebner’s 
phenomena[27] . The underlying factor in hyperlpidemic status is decreased 
lipoprotein lipase activity or increased LDL, making chylomicrons less able 
to compete LDL for lipoprotein lipase.  There are some evidence  that 
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eruptive xanthomas  in diabetics result from macrophage incorporating 
plasma lipoprotein  forming foam and xanthoma cells.  With correction of 
hyperlipidemia  and hyperglycemia, the lesions involute, sometimes with 
post inflammatory hyperpigmentation  and occationally scars.    
Bullous pemphigoids 
Theoretically, their association may be due to the lower threshold of 
the diabetes  in traumatically induced blisters or on the basis of enzymatic 
glycosylation. Steroids sometimes even immunosuppressive drugs may be 
appropriate. 
Dermatitis herpatiformis 
The HLA association of the diabetes and the dermatitis 
herpetiformis may be a possible explanation for the these two appearing 
together more frequently than expected.  
Psoriasis 
It is a multifactorial disease of unknown origin. There are a distinct 
pattern of associated diseases existing with psoarisis. Systemic disorders 
such as hypertension  and diabetes  are often seen in these patients. The 
resion for the diseases to occur in psoarisis patients have been related to 
nutritional factors of hypercaloric dietary habits[28] . 
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4 .MATERIALS AND METHODS 
 
Study design: 
 Cross sectional study. 
Methods of selection:  
1. All patients attending out patient department in Tirunelveli 
medical college hospital in medicine OPD, Dermatology OPD, 
and inpatients in Tirunelveli medical college hospital with or 
without referrence from various govt/private hospital in and 
around tirunelvel zone in tamil nadu. 
2. cross sectional study 
 
Inclusion Criteria: 
1. All adults. 
2. Individuals who attending all OPDs including Diabetic OPD 
during the period of May - October 2008 and May - October 
2009 till reaching the quota of 50 diabetic patients in a month. 
3. Patients admitted as IP in any of the Departments during the 
above period with diabetes. 
Exclusion criteria: 
1. Age less than 12 yrs. 
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Materials: 
 1. basis on the clinical examination 
 2. basis on the blood sugar value for the diagnosis of the diabetes 
         Six hundred diabetic patients attending the diabetic clinic, medical 
out-patient department and skin out-patient department and different 
wards of patients in  Tirunelveli Medical College Hospital, Tirunelveli, 
were studied. A detailed history and clinical examination, especially for 
the presence of cutaneous lesions, was carried out  during the period  from 
May 2008 to October2009. After investigations, patients with abnormal 
blood glucose levels were taken for study.  Fundus and routine blood, stool 
and urine examinations were carried out in all the patients. Blood sugar 
estimation was done by alkaline copper reduction method. Scrapping and 
direct KOH examination and culture for fungus in sabouraud's agar and 
gram staining and culture of the pus was done to identify the type of 
bacterial organism in selected cases. Histopathological examination of the 
skin sections was carried out wherever necessary to confirm the diagnosis. 
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5. RESULTS 
 
Table 5.1.1   OPD DM PATIENTS DETAILS MONTHWISE IN 2008 
 
2008 OPD SL DM  M F TYPE 
I 
TYPE 
II 
UNCLA 
SSIFIED 
SL 
IN 
DM  
MAY  422 32 50 24 26 3 40 7 11 
JUNE 350 42 50 29 21 4 42 4 12 
JULY 322 33 50 23 27 2 38 10 8 
AUG 480 37 50 26 24 2 41 7 9 
SEPT 384 41 50 28 22 4 40 6 11 
OCT 504 37 50 26 24 3 38 9 10 
TOTAL 2462 
 
222 
9.1% 
300 
12.2% 
156 
52.0% 
144 
48.0% 
18 
6.0% 
239 
79.7% 
43 
14.3% 
61 
20.3% 
 
 
Table 5.1.2   OPD DM PATIENTS DETAILS MONTHWISE IN 2009 
 
2009 OPD  SL DM  M F TYPE 
I 
TYPE 
II 
UNCLA 
SSIFIED 
SL 
IN 
DM  
MAY 340 32 50 23 27 3 41 6 9 
JUNE 401 27 50 28 22 2 43 5 8 
JULY 378 25 50 24 26 3 43 4 8 
AUG 420 30 50 22 28 2 40 8 9 
SEPT 390 35 50 27 23 3 39 8 9 
OCT 512 37 50 25 25 3 38 9 8 
TOTAL 2441 186 
7.6% 
300 
12.3% 
149 
49.6% 
151 
51.4% 
16 
5.3% 
244 
81.3% 
40 
13.3% 
51 
17% 
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Fig.5.1. OPD patients analysis year wise. 
 
Table 5.2.1   IP DM PATIENTS DETAILS 
 
YEAR TOTAL DM MALE FEMALE 
TOTAL 
SKIN 
LESIONS 
MALE FEMALE 
2008 422 220 202 70 36 34 
2009 307 156 151 64 33 31 
TOTAL 
729 
 
     376   
51.6% 
353  
48.4%     
   134 
18.4% 
   69 
51.5% 
65 
48.5 
 
 
Fig.5.2 .1 Sex distributions among IP DM patients 
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Fig-5.2.2 Sex distribution in DM IP patients with skin lesions. 
 
 
 
Fig. 5.2.3.  Proportion of Skin lesions among  IP DM patients. 
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Table 5.3 COMBINED OPD AND IP DM PATIENTS WITH SKIN 
LESIONS IN DETAILS 
 DM MALE FEMALE 
SKIN 
LESIONS MALE FEMALE 
OPD 600 305 295 112 57 55 
IP 729 376 353 134 69 65 
TOTAL 
1329 
 
681 
51.2% 
648 
48.8% 
246 
18.5% 
126 
51.2% 
120 
48.8% 
 
                              
 
Fig. 5.3.1  Sex Distribution in Diabetes 
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Fig. 5.3.2  Sex distribution in Skin Lesions associated with diabetes 
 
 
ANALYSIS OF DIABETIC PATIENTS (N=112) WITH SKIN LESIONS 
 
Table 5.4   SEX DISTRIBUTION 
SEX FREQUENCY PERCENTAGE 
MALE 55 49.1 
FEMALE 57 50.9 
TOTAL 112 100 
 
Table 5.5   AGE DISTRIBUTION 
SR.NO 
AGE 
GROUP FREQUENCY PERCENTAGE 
1  ≤30 14 12.5 
2 31 - 40 15 13.4 
3 41 -50 28 25.0 
4 51 -60 29 25.9 
5 >60 26 23.4 
 TOTAL  112 100 
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Table 5.6   DM TYPES 
 FREQUENCY PERCENTAGE 
TYPE I 3 2.7 
TYPE II 109 97.3 
 TOTL 112 100 
 
Table 5.7 DISTRIBUTIONS OF BS VALUES AND AGE 
 BSL FASTING BSL PP AGE 
Minimum 128 167 19 
Maximum 388 506 71 
Mean 182.91 286.33 49.7 
Median 176 269 49.5 
Standard 
deviation 47.187 66.134 13.19 
 
Table 5.8   DM COMPLICATIONS 
S. NO COMPLICATION FREQUENCY PERCENTAGE 
1 CAD 20 17.9 
2 MET.SYN 20 17.9 
3 DIA.RETINO 24 21.4 
4 DIA.NEPHRO 15 13.4 
5 PVD 15 13.4 
6 D.NEURO 27 24.1 
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5.9 RISK FACTORS FOR DM COMPLICATIONS 
 
 
Table 5.9.1   FBS >176 AND COMPLICATIONS 
 PRESENT ABSENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
CAD 17 40 7.367 11.333 0.001 
MET.SYN 15 42 3.571 5.666 0.015 
D.RETINOPATHY 22 35 16.657 20.139 0.0001 
D.NEPHROPATHY 13 44 7.83 8.869 0.003 
PVD 11 46 3.049 3.89 0.045 
D.NEUROPATHY 19 38 2.938 5.4 0.017 
FBS>176 is significantly associated with all the complications 
 
 
Table 5.9.2   PP>269 AND COMPLICATIONS 
 PRESENT ABSENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
CAD 18 39 12.231 14.899 0.0001 
MET.SYN 18 39 12.231 14.899 0.0001 
D.RETINOPATHY 22 35 16.657 20.319 0.0001 
D.NEPHROPATHY 14 43 17.581 12.482 0.0001 
PVD 12 45 4.662 5.871 0.014 
D.NEUROPATHY 22 35 6.286 13.319 0.0001 
PP > 269 is significantly associated with all the skin lesions 
 
 
 
 
 
 
 
 
 
Table 5.10   PATTERN OF SKIN LESIONS 
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SR.NO SKIN DISEASES FREQUENCY PERCENTAGE 
1 PRURITUS 14 12.5 
2 DIABETIC DERMOPATHY 3 2.7 
3 
NECROBIOSIS DIABETICA 
LIPOIDICORAM 2 1.8 
4 GRANULOMA ANNULARE 1 0.9 
5 DIABETIC BULLAE 3 2.7 
6 
SCELERODERMA LIKE 
SYNDROME 4 3.6 
7 DIABETIC FOOT 14 12.5 
8 FUNGAL INFECTION 19 17 
9 BACTERIAL INFECTION 14 12.5 
10 XANTHOMA 2 1.8 
11 INSULIN LIPODYSTROPHY 3 2.7 
12 CHANGES IN NAIL 6 5.4 
13 PERFORATING DERMATOSIS 7 6.3 
14 VITILIGO 3 2.7 
15 LICHEN PLANUS 4 3.6 
16 BULLOUS PEMPHIGOIDS 1 0.9 
17 DERMATITIS HERFATIFORMIS 2 1.8 
18 PSOARISIS 3 2.7 
19 ECZEMA 7 6.3 
 TOTAL 112 100 
 
The common presentations of the skin lesions are fungal infections 
followed by bacterial infection, diabetic foot, pruritis and perforating 
dermatosis. 
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                    Fig. 5.10 Frequency pattern of skin lesions in diabetics. 
  
 
5.11 RISK FACTORS ANALYSIS FOR SKIN LESIONS IN DM 
Table 5.11.1.  AGE>50 AND SKIN LESIONS 
 PRESENT ABSENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 3 52 0.241 4.905 0.025 
DIABETIC FOOT 10 45 2.944 3.89 0.046 
BACT.INFECTION 5 50 0.533 1.148 0.217 
FUNGAL 
INFECTION 7 48 0.547 1.377 0.179 
DERMATOSIS 3 50 0.764 0.117 0.521 
 
Age more than 50 years is significantly associated with pruritis and 
diabetic foot. 
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Table 5.11.2   SEX AND SKIN LESIONS 
SKIN LESION SEX PRE SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
MALE 8 49 1.333 0.25 0.416 
PRURITIS 
FEMALE 6 49    
MALE 6 51 0.691 0.413 0.361 
DIABETIC FOOT  
FEMALE 8 47    
MALE 7 50 0.96 0.005 0.584 
BACT.INFECTION  
FEMALE 7 48    
MALE 10 47 1.087 0.028 0.534 FUNGAL 
INFECTION  FEMALE 9 46    
MALE 3 54 0.708 0.193 0.48 PERFORATING 
DERMATOSIS  FEMALE 4 51    
 
Sex category is not having significant association with skin lesions. 
 
Table 5.11.3.   DM TYPE AND SKIN LESIONS 
SKIN LESION TYPE 
OF DM 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
TYPE I 0 3 1.147 0.44 0.667 PRURITIS 
TYPE II 14 95    
TYPE II 0 3  0.44 0.667 DIABETIC FOOT  
TYPE II 14 95    
TYPE I 1 2 3.692 1.223 0.373 BACT.INFECTION  
TYPE II 13 96    
TYPE I 1 2 2.528 0.586 0.431 FUNGAL 
INFECTION  TYPE II 18 91    
TYPE I 1 2 8.583 3.859 0.178 PERF.DERMATOSIS 
TYPE II 6 103    
DM type is not having the association with skin lesions. 
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Table 5.11.4   FBS > 176 AND SKIN LESIONS 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 5 52 0.49 1.475 0.171 
DIABETIC FOOT 14 43 0.754 15.439 0.001 
BACT.INFECTION 4 53 0.34 3.19 0.066 
FUNGAL 
INFECTION 7 50 0.502 1.808 0.137 
DERMATOSIS 4 53 1.308 0.117 0.52 
 
FBS >176 is significantly associated with Diabetic foot. 
 
Table 5.11.5   PP >269 AND SKIN LESIONS 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 5 52 0.491 1.478 0.177 
DIABETIC FOOT 13 44 15.955 11.274 0.001 
BACT.INFECTION 8 49 1.333 0.25 0.416 
FUNGAL 
INFECTION 5 52 0.282 5.53 0.97 
DERMATOSIS 4 53 1.308 0.117 0.52 
 
PP >269 is significantly associated with Diabetic foot. 
 
 
 
 
 
 
 
5.12. ASSOCIATION OF SKIN LESIONS WITH OTHER COMPLICATIONS 
OF DM 
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Table 5.12.1   CAD AND SKIN LESION 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 1 19 0.32 1.252 0.232 
DIABETIC FOOT 3 17 1.299 0.139 0.475 
BACT.INFECTION 2 18 0.741 0.139 0.525 
FUNGAL 
INFECTION 0 20 1.26 4.979 0.016 
DERMATOSIS 3 17 3.82 3.181 0.107 
 
CAD is significantly associated with fungal infections 
 
Table 5.12.2   METABOLIC SYNDROME AND SKIN LESIONS 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 1 19 0.32 1.252 0.235 
DIABETIC FOOT 4 16 2.05 1.252 0.22 
BACT.INFECTION 2 18 0.741 0.139 0.525 
FUNGAL 
INFECTION 0 20 1.26 4.094 0.016 
DERMATOSIS 2 18 1.933 0.584 0.365 
 
Metabolic syndrome is significantly associated with fungal infection. 
 
Table 5.12.3 DIABETIC RETINOPATHY AND SKIN  
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 2 22 0.576 0.485 0.383 
DIABETIC FOOT 7 17 4.765 7.75 0.011 
BACT.INFECTION 2 22 0.576 0.485 0.383 
FUNGAL 
INFECTION 0 24 1.275 5.24 0.006 
DERMATOSIS 1 23 0.594 0.226 0.534 
Diabetic Retinopathy is significantly associated with Diabetic foot and 
Fungal infection. 
Table 5.12.4   DIABETIC NEPHROPATHY AND SKIN LESIONS 
 PRE AB ODD CHI- P-
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SENT SENT RATIO SQUARE VALUE 
PRURITIS 1 4 0.462 0.539 0.407 
DIABETIC FOOT 2 13 1.09 0.011 0.593 
BACT.INFECTION 1 24 0.462 0.539 0.407 
FUNGAL 
INFECTION 0 15 1.244 3.638 0.04 
DERMATOSIS 1 14 1.083 0.005 0.645 
 
Diabetic Nephropathy is significantly associated with fungal infection 
 
 
Table 5.12.5   PVD AND SKIN LESIONS 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 0 15 1.16 2.474 0.116 
DIABETIC FOOT 3 12 1.955 0.891 0.281 
BACT.INFECTION 0 15 1.69 2.474 0.116 
FUNGAL 
INFECTION 0 18 1.244 3.538 0.048 
DERMATOSIS 1 14 1.083 0.005 0.645 
 
PVD is significantly associated with fungal infection 
 
Table 5.12.6   DIABETIC NEUROPATHY AND SKIN LESIONS 
 
PRE 
SENT 
AB 
SENT 
ODD 
RATIO 
CHI-
SQUARE 
P-
VALUE 
PRURITIS 0 27 1.192 5.082 0.016 
DIABETIC FOOT 5 22 1.919 1.178 0.221 
BACT.INFECTION 3 24 0.841 0.063 0.551 
FUNGAL 
INFECTION 4 23 0.812 0.117 0.495 
DERMATOSIS 3 24 2.531 1.435 0.22 
 
Diabetic Neuropathy is significantly associated with pruritis. 
 
6. DISCUSSION 
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During the study period of 2008 the total of 2462 cases were seen in 
the OPD till reaching the no 300 diabetes mellitus patients. So the 
prevalence of diabetic in general OPD is 12.2%.among these 2462 cases 222 
patients had skin lesions. The prevalence is 9.1%. Of the 300 diabetic 
patients 61 had skin lesions. So the prevalence of skin lesions in diabetics is 
20.3%. This is much higher than the prevalence of skin lesions in general 
population. It is supported by International Journal of diabetes in 
developing countries 20066. Of the 300 diabetic patients 156 were 
male(52%) and 144 were female(48%). Type I diabetes mellitus was 18(6%) 
and the type II diabetes mellitus were 239(79.71%) and 43 were unclassified 
(14.3%). (Refer Table 5.1.1)  
During the study period of 2009 the total of 2441 cases were seen in 
the OPD till reaching the no 300 diabetes mellitus patients. So the 
prevalence of diabetic in general OPD is 12.3%. Among these 2441 cases 
186 patients had skin lesions. The prevalence is 7.61%. Of the 300 diabetic 
patients 51 had skin lesions. So the prevalence of skin lesions in diabetes 
mellitus is 17%. This is much higher than the prevalence of skin lesions in 
general population. Of the 300 diabetic patients 149 were male(49.6%) and 
151 were female(51.4%). Type I diabetes mellitus was 16(5.3%) and the type 
II diabetes mellitus were 244(81.3%) and 40 were unclassified (13.3%). 
(Refer Table 5.1.2) 
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During the study period of 2008 and 2009 together the record of 729 
Diabetic patients were reviewed. Of them376 were male (51.6%) 353 were 
female (48.4) . Of them 134 had skin lesion (18.4%). 69 were male (51.5%) 
and 120 were female(48.5..%).(Refer Table 5.2.1) 
  In the combined analysis the details of 1329 diabetic patients were 
taken for analysis. Of them 600 from OPD  and 729 from IP. Of  them 
246(18.5) were having skin lesions. Of them 126 were male(51.2%)  120 
were female(48.8%). So the female are almost equally affected by skin 
lesion in diabetics. (Refer Table 5.3) 
In the OPD in 2008 and 2009 together totally 600 diabetics were seen. 
Of them 112 had skin lesion (61 in 2008 and 51 in 2009). These 112 patients 
were studied in details and taken for analysis. Of these 112 patients 55 
were male(49.1%) and 57 were female(50.9%). There was  no association of 
sex difference for skin lesions in diabetics(p value >0.05). (Refer Table 5.4)  
Regarding the age distribution of 112 patients the range was from 19 to 71. 
they were divided into each decade there was progressively increasing 
trends of skin lesion in diabetics. (Refer Table 5.5)  
The mean age of this study population were 49.70.so the age >50 and 
<50 were taken as cut off value for the analysis whether the age having 
significant risk on skin lesions in diabetics. There was significant 
association age >50 with occurrence of the skin lesions especially for 
pruritis and diabetic foot(p value <0.05) (Refer Table 5.7) 
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Of the 112 patients 3(2.7%)  were had type I diabetes mellitus 
and109(97.3) were typeII diabetes mellitus. Here the typeI is far lesser than 
the usual prevalence. The reason is the type I is more common in 
childhood and they have been excluded in this study. (Refer Table 5.6)  
The fasting and post prandial blood sugar value of these 112 patients were 
taken for analysis. The fasting BSL  ranged from 128 to 388 mg%.the 
median value was 176. the post prandial BSL ranged from 167 to 506.The 
median value is was tken as cut off value for analyzing the correlation of 
the BSL with skin lesions in diabetics. (Refer Table 5.7) 
Of the 112 diabetics with skin lesions the associated complications 
were analyzed. 20 (17.9%) had having CAD.20 (17.9%) had metabolic 
syndrome.24 (21.4%) of them had diabetic retinopathy. 15 (13.4) had 
having diabetic nephropathy. 15 (13.4) had  diabetic peripheral vascular 
diseases. And 27(24.1%) of them had having diabetic neuropathy. (Refer 
Table 5.8) 
The BSL as a risk factor for individual diabetic complications were 
analyzed. Fasting BSL >176 has statistically significant correlation with all 
the types of complications like  CAD(P value 0.001), Metabolic syndrome(P 
value 0.015), Diabetic retinopathy(P value 0.0001), Diabetic nephropathy(P 
value 0.003), Peripheral vascular diseases(P value 0.045), and Diabetic 
neuropathy(P value 0.017), in the same way the post prandial BSL >269 
also had the significant association with all the above said complications. 
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Post prandial value was more statistically significant correlation than the 
Fasting BSL value. (Refer Table 5.9.1. & 5.9.2)  
On observing the pattern of skin lesions in DM patients, the 
occurrence of Fungal infections are the most common (17%) followed by 
Bacterial infection (12.5%), Diabetic foot (12.5%), Pruritis (12.5%) and 
Perforating Dermatosis (6.3%) are the other common skin lesions in 
Diabetics. (Refer Table 5.10) 
The common presentations of the skin lesions observed in the study 
were further considered for the analysis of the association of the risk 
factors for the skin lesions in diabetics. Age > 50 was significantly 
associated with pruritis (P value 0.025) and diabetic foot P value 0.46). 
(Refer Table 5.11.1)  
  The Association of the sex with patters of the skin lesions were 
analyzed. Sex is not having the significant association with any if the 
common skin lesions. (Refer Table 5.11.2) 
The type of diabetes is not having the significant association with 
any of the common skin lesions in diabetics in this study (P value>0.05). 
The reason for this observation in this study was due to selection of the 
cases. There was only 3 cases of type I diabetes mellitus patients with skin 
lesions because children were excluded where the Type I diabetes more 
common. (Refer Table 5.11.3) 
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  Fasting BSL>176 is significantly associated with Diabetic foot (P 
value 0.001). (Refer Table 5.11.4)   In the same way post prandial >269 is 
also significantly associated with diabetic Foot (P value 0.001) (Refer Table 
5.11.5)  
The Association of Diabetic complications in cases of skin lesions 
with diabetics were analyzed. CAD is significantly associated with fungal 
infection (P value 0.016). (Refer Table 5.12.1)  Metabolic syndrome also 
significantly associated with fungal infection (P value 0.016) (Refer Table 
5.12.2).  Diabetic  retinopathy is significantly associated with Diabetic 
Foot(P value0.011) and fungal infection (P value 0.006). (Refer Table 5.12.3)   
Diabetic nephropathy is significantly associated with fungal infection (P 
value 0.04). (Refer Table 5.11.4). Peripheral vascular diseases is also 
significantly associated with fungal infection (P value 0.48). (Refer Table 
5.11.5)   Diabetic neuropathy is significantly associated with pruritis (P 
value 0.016). (Refer Table 5.11.6)  
From the above observation it is evident that fungal infections are 
significantly associated with CAD, Metabolic syndrome, Diabetic 
retinopathy, PVD (P value <0.05).  
 
 
7. CONCLUSION 
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1. The prevalence of the skin lesion in General population is12.2%. The 
skin lesions in diabetes mellitus is 20.3%. The skin lesions in general 
population is 9.1%. 
2. Increasing the Fasting and post prandial BSL has significant correlated 
with all the types of complications like CAD, Metabolic syndrome, 
Diabetic retinopathy, Diabetic nephropathy, Peripheral vascular 
diseases, and Diabetic neuropathy. Post prandial value was more 
statistically significant correlation than the Fasting BSL value. 
3. Diabetes mellitus with fungal infections are significantly associated 
with diabetes complications like CAD, Metabolic syndrome, Diabetic 
retinopathy, Diabetic nephropathy and peripheral vascular diseases. 
4. Diabetes mellitus with Diabetic Foot is significantly associated with 
Diabetic Retinopathy.  
5. Diabetes mellitus with prurites is significantly associated with Diabetic 
Neuropathy.  
6. The age >50 with occurrence of the skin lesions especially for pruritis 
and diabetic foot are common. 
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PROFORMA 
Patient  Name : 
Age  : 
Sex : 
 Ip/Op No : 
Address : 
Complaints : 
History Of Present Illness: 
        Mode Of Onset 
        Activity At The Time Of Illness 
        Time Of Onset 
        Associated Symptoms  
                     Haedache, Vomiting,  Altered Sensorium 
Past History : 
Family History : 
General Examination : 
Wt : 
BMI : 
Pulse : 
B P : 
Peripheral Vascular Disease : 
Funducopy : 
CVS  : 
       S1 S2 
       Murmur 
RS : 
   Air  Entry 
   Breath Sound 
Abdomen : 
   Organomegaly 
   Free Fluid 
CNS : 
           Neuropathy 
Skin Lesion : 
Pruritus  
Diabetic Dermopathy 
Necrobiosis Diabetica Lipoidicoram 
Granuloma Annulare 
Diabetic Bullae 
Sceleroderma Like Syndrome 
Diabetic Foot 
Fungal Infection 
Bacterial Infection 
Xanthoma 
Insulin Lipodystrophy 
Changes In Nail 
Perforating Dermatosis 
Vitiligo 
Lichen Planus 
Bullous Pemphigoids 
Dermatitis Herfatiformis 
Psoarisis 
Eczema                                                   
Complications of diabetes : 
CAD 
Metabolic syndrome 
Diabetic retinopathy 
Diabetic nephropathy 
Pvd 
Diabetic neuropathy 
Investigation : 
Blood sugar level -Ffasting/ Post prandial 
Blood urea 
Serum creatinine 
Lipid profile 
                  
 
                          Fig-1                                                             Fig-2 
 
Necrobiosis Lipoidica Diabeticorum (NLD) 
 
 
 
 
 
                    
 
                    Fig-3                                                         Fig-4 
 
          Diabetic Neuropathy of   Foot                  Granuloma  Annulare 
 
 
               
 
                         Fig-5                                                              Fig-6 
 
        Diabetic Thick Skin                           Spantaneous Blisters in Diabetes 
 
 
 
 
 
 
              
                    
 Fig-7                                                        Fig-8 
       Fungal Infection(Tinea cruris)               Candidal infection  with DM 
                       with DM            
  
                   
 
                       Fig-9                                                                   Fig-10 
 
Bacterial Infection With DM                        Eruptive xanthoma with DM 
 
 
 
 
                   
               
       
              Fig-11                                                                    Fig-12 
 
Diabetic Dermopathy 
 
                
 
                         Fig-13                                                        Fig-14 
 
        Periungual Telangiectasia                                   Xanthelasma     
  
 
 
 
                                              
                 
 Fig-15                                                               Fig-16 
 
              Pigmented purpura                                 Diabetic hand syndrome 
MASTER CHART 
SR. 
NO AGE  SEX 
DM 
TYPE 
BSL 
F 
BSL 
PP 
Type of Skin 
Lesions (Table 5.10) CAD MET.SYN D.RETINO D.NEPHR PVD D.NEURO 
1     30 M 2 138 224 8       
2             44 M 2 144 356 10 YES
3             44 F 2 165 306 14 YES YES
4           46 M 2 134 210 19   YES
5             48 F 2 130 240 1
6             58 M 2 237 350 7 YES YES YES YES
7         62 F 2 150 198 1     
8             24 F 1 178 320 9 YES
9             58 M 2 142 213 8 YES
10            60 M 2 130 310 1  
11             48 M 2 142 234 9
12             52 F 2 140 201 8
13             55 F 2 282 356 7 YES
14             44 M 2 165 406 2 YES YES YES YES YES
15        48 F 2 152 388 13      
16             52 F 2 162 231 19
17             62 M 2 172 253 13 YES
18             67 F 2 183 319 2 YES YES YES
19          19 M 1 198 412 8    YES
20            48 M 2 146 230 1  
21             44 M 2 210 310 7 YES YES YES
22          39 F 2 142 219 8    
SR. 
NO AGE  SEX 
DM 
TYPE 
BSL 
F 
BSL 
PP 
Type of Skin 
Lesions (Table 5.10) CAD MET.SYN D.RETINO D.NEPHR PVD D.NEURO 
23     48 M 2 132 298 19     YES  
24            52 F 2 139 294 8  
25             28 M 2 187 328 1
26             39 F 2 158 296 10 YES YES
27            42 M 2 176 289 17  YES
28            48 F 1 200 329 13  
29             59 M 2 276 348 7 YES
30            57 F 2 158 242 9  
31             34 M 2 187 410 1 YES YES YES
32          68 M 2 208 265 18    
33             49 F 2 136 256 1
34             38 M 2 145 240 15
35             62 F 2 208 355 6 YES YES YES YES
36         61 M 2 145 209 8     
37             58 M 2 193 388 9 YES YES YES YES YES
38        44 F 2 153 210 12      
39             29 F 2 142 272 9
40             52 F 2 128 230 5
41             49 M 2 210 344 7 YES YES YES YES
42          66 F 2 134 243 13    YES
43            67 F 2 178 417 12 YES YES YES YES  
44         39 M 2 234 231 8     
45             49 F 2 278 210 7
46             58 F 2 143 230 9
SR. 
NO AGE  SEX 
DM 
TYPE 
BSL 
F 
BSL 
PP 
Type of Skin 
Lesions (Table 5.10) CAD MET.SYN D.RETINO D.NEPHR PVD D.NEURO 
47     54 M 2 150 280 14       
48             70 M 2 156 356 2 YES YES YES YES YES
49         68 F 2 144 298 3 YES     
50            63 M 2 132 217 9  
51             59 F 2 188 267 6 YES YES YES
52          48 F 2 177 301 1    
53             55 M 2 198 312 4 YES YES
54           28 F 2 143 219 1   
55             59 F 2 188 254 8
56             49 M 2 256 329 13 YES YES YES YES
57         63 F 2 245 398 7     
58             69 M 2 214 321 5
59             70 F 2 211 243 18 YES
60            67 F 2 132 243 12  
61             51 M 2 202 256 6
62             38 F 2 187 234 13 YES YES YES YES
63             55 F 2 198 298 11 YES YES YES YES
64         27 M 2 143 254 19     
65             39 M 2 178 276 8 YES
66            32 F 2 145 245 15  
67             59 M 2 199 312 7
68             42 M 2 145 243 9
69             61 M 2 205 278 7 YES YES
70           32 F 2 176 213 19   
SR. 
NO AGE  SEX 
DM 
TYPE 
BSL 
F 
BSL 
PP 
Type of Skin 
Lesions (Table 5.10) CAD MET.SYN D.RETINO D.NEPHR PVD D.NEURO 
71     45 M 2 167 254 15      YES 
72            49 F 2 134 213 8  
73             71 F 2 156 239 8
74             29 M 2 172 219 19
75             62 F 2 256 321 7 YES YES
76           39 M 2 167 243 8   
77             48 M 2 199 265 17
78             37 F 2 165 388 8 YES
79            29 F 2 165 269 9  
80             62 M 2 269 389 7 YES
81            57 F 2 178 249 14  YES
82            49 M 2 160 254 16  YES
83            31 F 2 143 210 8  
84             25 M 2 132 211 1
85             59 M 2 298 438 12 YES YES YES YES YES
86           62 F 2 204 349 11 YES  YES YES  
87          37 M 2 145 239 9    
88             60 M 2 138 232 19
89             23 M 2 152 219 8
90             52 F 2 388 506 11 YES YES YES
91          50 M 2 198 230 15    
92             49 M 2 138 204 1
93             46 F 2 306 408 7
94             55 F 2 188 269 12
SR. 
NO AGE  SEX 
DM 
TYPE 
BSL 
F 
BSL 
PP 
Type of Skin 
Lesions (Table 5.10) CAD MET.SYN D.RETINO D.NEPHR PVD D.NEURO 
95     66 M 2 209 299 3 YES  YES YES   
96            71 F 2 231 378 6 YES YES  YES YES
97         22 F 2 154 218 1     
98             52 F 2 188 298 8
99             29 M 2 198 278 9
100             43 F 2 166 298 9
101             49 M 2 188 245 8
102             37 M 2 187 254 1
103             68 F 2 254 276 5 YES YES YES YES
104           70 M 2 179 354 1 YES YES   
105           69 M 2 145 167 18   
106             28 F 2 187 261 8
107             58 M 2 276 312 13 YES
108            67 F 2 232 324 7  YES
109            52 M 2 178 265 12  
110             39 F 2 145 324 9
111             55 M 2 276 444 7 YES YES YES
112           59 M 2 273 389 9 YES YES YES   YES
 
 
